Suppr超能文献

疟原虫蛋白 K13 的 Kelch 突变不会影响青蒿素暴露和山梨醇选择后的休眠。

Kelch Mutations in Plasmodium falciparum Protein K13 Do Not Modulate Dormancy after Artemisinin Exposure and Sorbitol Selection .

机构信息

Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Radcliffe Department of Medicine, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.

出版信息

Antimicrob Agents Chemother. 2018 Apr 26;62(5). doi: 10.1128/AAC.02256-17. Print 2018 May.

Abstract

Some Kelch mutations of the K13 protein confer increased survival to dihydroartemisinin (DHA)-treated ring-stage parasites. Here, we asked if K13 mutations affect a dormancy phenotype allowing parasites to survive DHA exposure and then sorbitol selection. Although recrudescence from dormancy differed between two distinct parasite lines, it was similar for isogenic lines carrying single-site substitutions in K13. Therefore, K13 mutations do not alter the DHA-sorbitol combined dormancy phenotype; rather, traits from other loci likely determine this phenotype.

摘要

一些 Kelch 蛋白的突变使疟原虫对二氢青蒿素(DHA)处理的环状期寄生虫的存活能力增加。在这里,我们想知道 K13 突变是否会影响休眠表型,使寄生虫能够在 DHA 暴露后和山梨醇选择中存活。尽管两种不同的寄生虫系之间的复发从休眠中有所不同,但携带 K13 单点突变的同基因系之间的差异相似。因此,K13 突变不会改变 DHA-山梨醇联合休眠表型;相反,其他基因座的特征可能决定了这种表型。

相似文献

引用本文的文献

3
Artemisinin-resistant malaria.抗青蒿素疟疾
Clin Microbiol Rev. 2024 Dec 10;37(4):e0010924. doi: 10.1128/cmr.00109-24. Epub 2024 Oct 15.
9
Nutrient Limitation Mimics Artemisinin Tolerance in Malaria.营养限制模拟青蒿素耐药性在疟疾中。
mBio. 2023 Jun 27;14(3):e0070523. doi: 10.1128/mbio.00705-23. Epub 2023 Apr 25.

本文引用的文献

4
Dihydroartemisinin-piperaquine failure in Cambodia.双氢青蒿素-哌喹在柬埔寨治疗失败
N Engl J Med. 2014 Jul 31;371(5):484-5. doi: 10.1056/NEJMc1403007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验